
|Videos|April 27, 2020
Evolving Models in Specialty Pharmacy
Thom Cohn, chief strategy officer, Asembia, discusses recent developments in specialty pharmacy models.
Advertisement
Thom Cohn, chief strategy officer, Asembia, discusses recent developments in specialty pharmacy models.
Thom Cohn: Well, the specialty model is evolving, and there's been a lot of recent developments in specialty pharmacy, whether it's new therapies, digital therapies, digital solutions for patients, or just new ways to interact with patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
5












































































































































































































